Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies.The test helps clinicians quickly identify heart attack and ...

One study examines the small molecular cardiac myosin inhibitor for safety and efficacy at 96 weeks, and another compares it ...

Roche has announced results from the TSIX Study Program, showing that its sixth-generation high-sensitivity Troponin T test ...

Cytokinetics (CYTK) announced that additional data related to aficamten were presented in a Late Breaking Clinical Research session at the Heart ...

A study by two Indiana University School of Medicine doctors has unveiled a new purpose for a widely used blood test for ...

Aficamten is also currently being evaluated in ACACIA-HCM, a Phase 3 clinical trial of aficamten in patients with non-obstructive HCM; CEDAR-HCM, a clinical trial of aficamten in a pediatric ...